TYK2 modulators (Celgene/Array BioPharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTYK2 modulators (Celgene/Array BioPharma)
Drug Alias NameARRY-111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 modulators
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArray Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelgene CorpArray Biopharma Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A